Expression of interleukin-6 receptors by pediatric acute lymphoblastic leukemia cells with the t(4;11) translocation: A possible target for therapy with recombinant IL6-Pseudomonas exotoxin

Leukemia

Volumn 11, Issue 10, 1997, Pages 1779-1786

  Gu, L ^a   Zhou, M ^a   Jurickova, I ^a   Yeager, A M ^a   Kreitman, R J ^c   Phillips, C N ^b   Findley, H W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ALL; IL6 Pseudomonas exotoxin; Interleukin 6 receptor

Indexed keywords

CD33 ANTIGEN; GLUTAMINE; HYBRID PROTEIN; INTERLEUKIN 6 RECEPTOR; PSEUDOMONAS EXOTOXIN; RECOMBINANT INTERLEUKIN 6;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; CELL VIABILITY; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 4; CLINICAL ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; SCATCHARD PLOT; SCID MOUSE;

EID: 0030704212     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400757     Document Type: Article

References (13)

1. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237-2250.
2. Childs C, Hirsch-Ginsberg C, Culbert S, Ahearn M, Reuben J, Trujillo J, Cork A, Walters R, Freireich EJ. Lineage heterogeneity in acute leukemia with the t(4;11 ) abnormality: implications for acute mixed lineage leukemia. Hematol Pathol 1988; 2: 145-157.
3. Pui C-H, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land V, Pullen D, Steuber CP, Behm FG, Borowitz MJ. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 1991; 77: 440-447.
4. Pui C-H. Acute leukemias with the t(4;11)(q21;q23). Leuk Lymphoma 1992; 7: 173-179.
5. Altman A. Clinical features and biological implications of acute mixed lineage (hybrid) leukemias. Am J Ped Hematol Oncol 1990; 12: 123-133.
6. Demetri G, Griffin J. Hemopoietins and leukemia. Hematol/Oncol Clin N Am 1989; 3: 535-552.
7. O'Connor R, Cesano A, Lange B, Finan J, Nowell P, Clark S, Raimondi S, Rovera G, Santoli D. Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro. Blood 1991; 77: 1534-1545.
8. Lowenberg B, Touw I. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281-292.
9. Uckun F. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908-1923.
10. Lopez M, Maroc N, Kerangueven F, Bardin F, Courcoul M, Lavezzi C, Birg F, Mannoni P. Coexpression of the genes for interleukin-6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells. Exp Hematol 1991; 19: 797-803.
11. Inoue K, Sugiyama H, Ogawa H, Yamagami T, Azuma T, Oka Y, Miwa H, Kenkichi K, Kishimoto T. Expression of interleukin-6 (IL-6), IL-6 receptor, and gp130 genes in acute leukemia. Blood 1994; 84: 2672-2680.
12. Sugiyama H, Inoue K, Ogawa H, Yamagami T, Soma T, Miyake S, Hirata M, Kishimoto T. The expression of IL-6 and its related genes in acute leukemia. Leuk Lymphoma 1996; 212: 49-58.
13. Siegall CB, Fitzgerald DJ, Pastan I. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin-6 receptor levels. J Biol Chem 1990; 265: 16318-16323.